{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:30:34Z","timestamp":1791851434367,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.cct.2024.107440","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T20:18:25Z","timestamp":1705609105000},"page":"107440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparison of baseline covariate adjustment methods for restricted mean survival time"],"prefix":"10.1016","volume":"138","author":[{"given":"Keisuke","family":"Hanada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.cct.2024.107440_bb0005","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non\u2013small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cct.2024.107440_bb0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without braf mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.cct.2024.107440_bb0015","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"Spruance","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"22","key":"10.1016\/j.cct.2024.107440_bb0020","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1200\/JCO.2014.55.2208","article-title":"Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis","volume":"32","author":"Uno","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.cct.2024.107440_bb0025","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/biom.13237","article-title":"On the empirical choice of the time window for restricted mean survival time","volume":"76","author":"Tian","year":"2020","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.cct.2024.107440_bb0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/pst.1846","article-title":"Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point","volume":"17","author":"Huang","year":"2018","journal-title":"Pharm. Stat."},{"issue":"400","key":"10.1016\/j.cct.2024.107440_bb0035","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1080\/01621459.1987.10478555","article-title":"Restricted mean life with adjustment for covariates","volume":"82","author":"Karrison","year":"1987","journal-title":"J. Am. Stat. Assoc."},{"issue":"442","key":"10.1016\/j.cct.2024.107440_bb0040","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/01621459.1998.10473722","article-title":"Restricted mean life with covariates: modification and extension of a useful survival analysis method","volume":"93","author":"Zucker","year":"1998","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.cct.2024.107440_bb0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10985-004-4771-0","article-title":"Regression analysis of restricted mean survival time based on pseudo-observations","volume":"10","author":"Andersen","year":"2004","journal-title":"Lifetime Data Anal."},{"issue":"2","key":"10.1016\/j.cct.2024.107440_bb0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/biostatistics\/kxt050","article-title":"Predicting the restricted mean event time with the subject\u2019s baseline covariates in survival analysis","volume":"15","author":"Tian","year":"2014","journal-title":"Biostatistics"},{"key":"10.1016\/j.cct.2024.107440_bb0055","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1002\/sim.9495","article-title":"Restricted mean survival time regression model with time-dependent covariates","volume":"41","author":"Zhang","year":"2022","journal-title":"Stat. Med."},{"issue":"1","key":"10.1016\/j.cct.2024.107440_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-022-01559-z","article-title":"Analyzing differences between restricted mean survival time curves using pseudo-values","volume":"22","author":"Ambrogi","year":"2022","journal-title":"BMC Med. Res. Methodol."},{"issue":"2","key":"10.1016\/j.cct.2024.107440_bb0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/1740774518759281","article-title":"Restricted mean survival time: does covariate adjustment improve precision in randomized clinical trials?","volume":"15","author":"Karrison","year":"2018","journal-title":"Clin. Trials"},{"issue":"1","key":"10.1016\/j.cct.2024.107440_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-13-152","article-title":"Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.cct.2024.107440_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/biomet\/90.1.15","article-title":"Generalised linear models for correlated pseudo-observations, with applications to multi-state models","volume":"90","author":"Andersen","year":"2003","journal-title":"Biometrika"},{"issue":"2","key":"10.1016\/j.cct.2024.107440_bb0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/19466315.2019.1697738","article-title":"Alternative analysis methods for time to event endpoints under nonproportional hazards: a comparative analysis","volume":"12","author":"Lin","year":"2020","journal-title":"Stat. Biopharm. Res."},{"issue":"10","key":"10.1016\/j.cct.2024.107440_bb0085","first-page":"28","article-title":"Package \u2018survival\u2019","volume":"128","author":"Therneau","year":"2015","journal-title":"R Top. Doc."},{"issue":"8956","key":"10.1016\/j.cct.2024.107440_bb0090","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","article-title":"Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas","volume":"345","author":"Brem","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2024.107440_bb0095","series-title":"Clinical Trials: A Methodologic Perspective","author":"Piantadosi","year":"2017"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:02:17Z","timestamp":1761555737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714424000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":19,"alternative-id":["S1551714424000144"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2024.107440","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of baseline covariate adjustment methods for restricted mean survival time","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2024.107440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107440"}}